PrimeWire Prestige Plus
Related Content
Jan. 13, — A new cohort study among 103,642 adults found that current use of cigars was associated with increased risk ...
Nov. 22, 2024 — BridgeBio Pharma, Inc. recently announced that the U.S. Food and Drug Administration (FDA) approved ...
Nov. 18, 2024 — Silence Therapeutics presented end-of-treatment data from its Phase 2 ALPACAR-360 study of zerlasiran, a ...
Aug. 15, 2024 — According to a new study being presented at ACC Asia 2024 in Delhi, India, drinking over 400 mg of ...
As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits ...
July 25, 2024 — BioCardia, Inc., a global leader in cellular and cell-derived therapeutics for the treatment of ...
July 18, 2024 — Elucid, a pioneering AI medical technology company providing physicians with imaging analysis software ...
July 10, 2024 — CellProthera, a private company specializing in cell-based therapies for repairing ischemic tissues, and ...
July 9, 2024 — Microbot Medical Inc. announced the completion of the first procedure in a patient utilizing its LIBERTY ...
June 26, 2024 — Semaglutide, a medication initially developed for type 2 diabetes and obesity, significantly improves ...